Teachers Retirement System of The State of Kentucky Boosts Stake in The Clorox Company $CLX

Teachers Retirement System of The State of Kentucky raised its position in shares of The Clorox Company (NYSE:CLXFree Report) by 1,739.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,599 shares of the company’s stock after buying an additional 167,000 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Clorox were worth $18,301,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Clorox during the 4th quarter valued at approximately $135,735,000. Invesco Ltd. raised its stake in Clorox by 22.1% during the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in Clorox by 6,907.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares during the last quarter. Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox in the 2nd quarter worth $71,856,000. Finally, Two Sigma Investments LP grew its stake in shares of Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $95.09 on Tuesday. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a market cap of $11.50 billion, a PE ratio of 15.44, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The business has a 50-day simple moving average of $94.07 and a two-hundred day simple moving average of $104.10.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox’s revenue was up .1% on a year-over-year basis. During the same period last year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts expect that The Clorox Company will post 5.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CLX. BNP Paribas Exane decreased their target price on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 target price on shares of Clorox in a research note on Friday, May 1st. Barclays dropped their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Evercore reissued an “underperform” rating and set a $110.00 target price on shares of Clorox in a research report on Friday, May 1st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Friday. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $103.40.

View Our Latest Stock Report on Clorox

Insider Activity

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.